Table of Contents
1 Table of Contents 3
1.1 List of Tables 7
1.2 List of Figures 8
2
Introduction 9
2.1 What Is This Report About? 9
3 Definitions of the
Markets/Categories Covered 10
3.1 In Vitro Diagnostics 10
3.1.1
Infectious Immunology Test Reagents 10
4 Company Snapshot 11
4.1 Key
Information 11
4.2 Company Overview 11
4.3 Financial Performance
11
4.4 Industry Outlook -- In Vitro Diagnostics 11
5 Business
Description 13
5.1 Business Overview 13
5.2 Major Products and
Services 14
5.2.1 Overview 14
6 Competitors 15
7 Digene
Corporation Medical Equipment Market Share Analysis by Category 16
7.1
Digene Corporation, Global, In Vitro Diagnostics by Category, Market Share
(2007) 16
7.2 Digene Corporation, APAC, In Vitro Diagnostics by Category,
Market Share (2007) 17
7.3 Digene Corporation, Europe, In Vitro
Diagnostics by Category, Market Share (2007) 18
7.4 Digene Corporation,
North America, In Vitro Diagnostics by Category, Market Share (2007) 19
8
Key Employees 20
9 Key Employee Biographies 21
10 Company Statement
23
11 Locations And Subsidiaries 25
11.1 Head Office 25
11.2 Other
Locations & Subsidiaries 25
12 Financial Deals Landscape 27
12.1
Acquisition 27
12.1.1 QIAGEN Acquires Digene 27
12.2 IPO 29
12.2.1
Digene Completes Common Stock Offering 29
12.2.2 Digene Enters Into an
Agreement with Asuragen 31
13 Recent Developments 33
13.1 Product
Announcements 33
13.1.1 Oct 18, 2007 HPV Test More Accurate Than Pap
Smear In Detecting Cervical Cancer 33
13.1.2 May 11, 2007 Digene
Research at Clinical Virology Symposium Shows Strides in Multiplex Genotyping
Technology Development 33
13.1.3 Apr 19, 2007 Digene Announces Exclusive
Marketing and Distribution Agreement with Asuragen, Inc. for Signature Cystic
Fibrosis Screening Products. 33
13.1.4 Mar 08, 2007 Detecting High-Risk
HPV in Older Women 34
13.1.5 Dec 19, 2007: QIAGEN, Ventana Announce
Settlement of Patent Dispute 34
13.2 Financial Announcements 34
13.2.1
May 08, 2007: Digene Reports Q3 Fiscal 2007 Results 34
13.2.2 Feb 01,
2007: Digene Reports Q2 Fiscal 2007 Results 35
13.2.3 Nov 02, 2006: Digene
Reports Q1 Fiscal 2007 Results 36
13.2.4 Aug 08, 2006: Digene Reports
Fiscal Year-End 2006 Results 37
13.3 Other Significant Developments 39
13.3.1 Nov 14, 2006: Digene Appoints New CEO and Director 39
13.3.2 Aug
23, 2006: Digene President, COO and CFO Resigns 39
14 Digene Corporation
Pipeline Products 40
14.1 Customized HPV test 40
14.1.1 Product
Overview 40
14.1.2 Product Description 40
14.1.3 Product Status 40
14.1.4 Product Milestone 41
14.2 Next generation cystic fibrosis test
41
14.2.1 Product Overview 41
14.2.2 Product Description 41
14.2.3
Product Status 42
14.2.4 Product Milestone 42
14.3 Multiplex
instrument 42
14.3.1 Product Overview 42
14.3.2 Product Description
43
14.3.3 Product Status 43
14.3.4 Product Milestone 43
15
Appendix 45
15.1 Global Markets Direct Research Methodology 45
15.2
Coverage 46
15.3 Secondary Research 46
15.4 Primary Research 47
15.5 Models 47
15.6 Forecasts 48
15.7 Expert Panels 48
15.8 Market
Revenue Chapters 48
15.8.1 Abbreviations 48
15.8.2 Currency
Conversions 49
15.9 About Global Markets Direct 50
15.10 Contact Us
50
15.11 Disclaimer 50
View Cart
